メディカルプロバイオティクス世界市場の発展状況と動向 2024-2030
英文タイトル: Global Medical Probiotics Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、メディカルプロバイオティクスの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にメディカルプロバイオティクス市場を分類しています。本レポートでは世界のメディカルプロバイオティクス市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:DowDuPont、Chr. Hansen、Lallemand、China-Biotics、Nestle、Danone、Probi、BioGaia、Novozymes、DSM、Ganeden、Glory Biotech、Unique Biotech、Winclove Probiotics、UAS Laboratories、Synbiotech
レポートはメディカルプロバイオティクスの主要生産者を調査し、主要地域や国の消費状況も提供します。メディカルプロバイオティクスの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)のメディカルプロバイオティクス生産量、成長率、市場シェアを調査している。
Bifidobacterium
Lactobacillus
Others
用途別の市場セグメント:
Pharmaceuticals
Dietary Supplements
Others
本レポートの詳細内容
本レポートは、世界のメディカルプロバイオティクス市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてメディカルプロバイオティクス市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、メディカルプロバイオティクスの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーのメディカルプロバイオティクス売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のメディカルプロバイオティクス市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本メディカルプロバイオティクスのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:メディカルプロバイオティクスのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2019~2030)
第2章: メディカルプロバイオティクスの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2019~2030)
第3章:世界、地域、国レベルにおけるメディカルプロバイオティクスの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2019~2030)
第4章メディカルプロバイオティクスメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2019~2024)
第5章:メディカルプロバイオティクスの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2019~2030)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2019~2030)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2019~2030)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第12章:メディカルプロバイオティクスの主要メーカーの概要を提供し、製品の説明と仕様、メディカルプロバイオティクスの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2019~2024)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:メディカルプロバイオティクスの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
Medical probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of dietary supplements and healthcare products. The global Medical Probiotics market is projected to grow from US$ 73 million in 2024 to US$ 92 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. The US & Canada market for Medical Probiotics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for Medical Probiotics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The Europe market for Medical Probiotics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The global key manufacturers of Medical Probiotics include DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc. In 2023, the global top five players had a share approximately % in terms of revenue. Report Covers: This report presents an overview of global market for Medical Probiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Medical Probiotics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Medical Probiotics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Medical Probiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Medical Probiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Medical Probiotics sales, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc. Market Segmentation By Company DowDuPont Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Novozymes DSM Ganeden Glory Biotech Unique Biotech Winclove Probiotics UAS Laboratories Synbiotech Segment by Type Bifidobacterium Lactobacillus Others Segment by Application Pharmaceuticals Dietary Supplements Others Segment by Region US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Sales (consumption), revenue of Medical Probiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 3: Detailed analysis of Medical Probiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment. Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: China by Type, and by Application, sales, and revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Probiotics sales, revenue, price, gross margin, and recent development, etc. Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers. Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 14: The main points and conclusions of the report.
総目録
1 Study Coverage
1.1 Medical Probiotics Product Introduction
1.2 Market by Type
1.2.1 Global Medical Probiotics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bifidobacterium
1.2.3 Lactobacillus
1.2.4 Others
1.3 Market by Application
1.3.1 Global Medical Probiotics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Dietary Supplements
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Probiotics Sales Estimates and Forecasts 2019-2030
2.2 Global Medical Probiotics Revenue by Region
2.2.1 Global Medical Probiotics Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Medical Probiotics Revenue by Region (2019-2024)
2.2.3 Global Medical Probiotics Revenue by Region (2025-2030)
2.2.4 Global Medical Probiotics Revenue Market Share by Region (2019-2030)
2.3 Global Medical Probiotics Sales Estimates and Forecasts 2019-2030
2.4 Global Medical Probiotics Sales by Region
2.4.1 Global Medical Probiotics Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Medical Probiotics Sales by Region (2019-2024)
2.4.3 Global Medical Probiotics Sales by Region (2025-2030)
2.4.4 Global Medical Probiotics Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Medical Probiotics Sales by Manufacturers
3.1.1 Global Medical Probiotics Sales by Manufacturers (2019-2024)
3.1.2 Global Medical Probiotics Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Probiotics in 2023
3.2 Global Medical Probiotics Revenue by Manufacturers
3.2.1 Global Medical Probiotics Revenue by Manufacturers (2019-2024)
3.2.2 Global Medical Probiotics Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Medical Probiotics Revenue in 2023
3.3 Global Key Players of Medical Probiotics, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Medical Probiotics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Medical Probiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Medical Probiotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Medical Probiotics, Product Offered and Application
3.8 Global Key Manufacturers of Medical Probiotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Probiotics Sales by Type
4.1.1 Global Medical Probiotics Historical Sales by Type (2019-2024)
4.1.2 Global Medical Probiotics Forecasted Sales by Type (2025-2030)
4.1.3 Global Medical Probiotics Sales Market Share by Type (2019-2030)
4.2 Global Medical Probiotics Revenue by Type
4.2.1 Global Medical Probiotics Historical Revenue by Type (2019-2024)
4.2.2 Global Medical Probiotics Forecasted Revenue by Type (2025-2030)
4.2.3 Global Medical Probiotics Revenue Market Share by Type (2019-2030)
4.3 Global Medical Probiotics Price by Type
4.3.1 Global Medical Probiotics Price by Type (2019-2024)
4.3.2 Global Medical Probiotics Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Medical Probiotics Sales by Application
5.1.1 Global Medical Probiotics Historical Sales by Application (2019-2024)
5.1.2 Global Medical Probiotics Forecasted Sales by Application (2025-2030)
5.1.3 Global Medical Probiotics Sales Market Share by Application (2019-2030)
5.2 Global Medical Probiotics Revenue by Application
5.2.1 Global Medical Probiotics Historical Revenue by Application (2019-2024)
5.2.2 Global Medical Probiotics Forecasted Revenue by Application (2025-2030)
5.2.3 Global Medical Probiotics Revenue Market Share by Application (2019-2030)
5.3 Global Medical Probiotics Price by Application
5.3.1 Global Medical Probiotics Price by Application (2019-2024)
5.3.2 Global Medical Probiotics Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Medical Probiotics Market Size by Type
6.1.1 US & Canada Medical Probiotics Sales by Type (2019-2030)
6.1.2 US & Canada Medical Probiotics Revenue by Type (2019-2030)
6.2 US & Canada Medical Probiotics Market Size by Application
6.2.1 US & Canada Medical Probiotics Sales by Application (2019-2030)
6.2.2 US & Canada Medical Probiotics Revenue by Application (2019-2030)
6.3 US & Canada Medical Probiotics Market Size by Country
6.3.1 US & Canada Medical Probiotics Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Medical Probiotics Sales by Country (2019-2030)
6.3.3 US & Canada Medical Probiotics Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Medical Probiotics Market Size by Type
7.1.1 Europe Medical Probiotics Sales by Type (2019-2030)
7.1.2 Europe Medical Probiotics Revenue by Type (2019-2030)
7.2 Europe Medical Probiotics Market Size by Application
7.2.1 Europe Medical Probiotics Sales by Application (2019-2030)
7.2.2 Europe Medical Probiotics Revenue by Application (2019-2030)
7.3 Europe Medical Probiotics Market Size by Country
7.3.1 Europe Medical Probiotics Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Medical Probiotics Sales by Country (2019-2030)
7.3.3 Europe Medical Probiotics Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Medical Probiotics Market Size
8.1.1 China Medical Probiotics Sales (2019-2030)
8.1.2 China Medical Probiotics Revenue (2019-2030)
8.2 China Medical Probiotics Market Size by Application
8.2.1 China Medical Probiotics Sales by Application (2019-2030)
8.2.2 China Medical Probiotics Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Medical Probiotics Market Size by Type
9.1.1 Asia Medical Probiotics Sales by Type (2019-2030)
9.1.2 Asia Medical Probiotics Revenue by Type (2019-2030)
9.2 Asia Medical Probiotics Market Size by Application
9.2.1 Asia Medical Probiotics Sales by Application (2019-2030)
9.2.2 Asia Medical Probiotics Revenue by Application (2019-2030)
9.3 Asia Medical Probiotics Sales by Region
9.3.1 Asia Medical Probiotics Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Medical Probiotics Revenue by Region (2019-2030)
9.3.3 Asia Medical Probiotics Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Medical Probiotics Market Size by Type
10.1.1 Middle East, Africa and Latin America Medical Probiotics Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Medical Probiotics Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Medical Probiotics Market Size by Application
10.2.1 Middle East, Africa and Latin America Medical Probiotics Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Medical Probiotics Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Medical Probiotics Sales by Country
10.3.1 Middle East, Africa and Latin America Medical Probiotics Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Medical Probiotics Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Medical Probiotics Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 DowDuPont
11.1.1 DowDuPont Company Information
11.1.2 DowDuPont Overview
11.1.3 DowDuPont Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 DowDuPont Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 DowDuPont Recent Developments
11.2 Chr. Hansen
11.2.1 Chr. Hansen Company Information
11.2.2 Chr. Hansen Overview
11.2.3 Chr. Hansen Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Chr. Hansen Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chr. Hansen Recent Developments
11.3 Lallemand
11.3.1 Lallemand Company Information
11.3.2 Lallemand Overview
11.3.3 Lallemand Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Lallemand Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lallemand Recent Developments
11.4 China-Biotics
11.4.1 China-Biotics Company Information
11.4.2 China-Biotics Overview
11.4.3 China-Biotics Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 China-Biotics Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 China-Biotics Recent Developments
11.5 Nestle
11.5.1 Nestle Company Information
11.5.2 Nestle Overview
11.5.3 Nestle Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Nestle Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nestle Recent Developments
11.6 Danone
11.6.1 Danone Company Information
11.6.2 Danone Overview
11.6.3 Danone Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Danone Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Danone Recent Developments
11.7 Probi
11.7.1 Probi Company Information
11.7.2 Probi Overview
11.7.3 Probi Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Probi Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Probi Recent Developments
11.8 BioGaia
11.8.1 BioGaia Company Information
11.8.2 BioGaia Overview
11.8.3 BioGaia Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BioGaia Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BioGaia Recent Developments
11.9 Novozymes
11.9.1 Novozymes Company Information
11.9.2 Novozymes Overview
11.9.3 Novozymes Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Novozymes Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novozymes Recent Developments
11.10 DSM
11.10.1 DSM Company Information
11.10.2 DSM Overview
11.10.3 DSM Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 DSM Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 DSM Recent Developments
11.11 Ganeden
11.11.1 Ganeden Company Information
11.11.2 Ganeden Overview
11.11.3 Ganeden Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Ganeden Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ganeden Recent Developments
11.12 Glory Biotech
11.12.1 Glory Biotech Company Information
11.12.2 Glory Biotech Overview
11.12.3 Glory Biotech Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Glory Biotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Glory Biotech Recent Developments
11.13 Unique Biotech
11.13.1 Unique Biotech Company Information
11.13.2 Unique Biotech Overview
11.13.3 Unique Biotech Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Unique Biotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Unique Biotech Recent Developments
11.14 Winclove Probiotics
11.14.1 Winclove Probiotics Company Information
11.14.2 Winclove Probiotics Overview
11.14.3 Winclove Probiotics Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Winclove Probiotics Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Winclove Probiotics Recent Developments
11.15 UAS Laboratories
11.15.1 UAS Laboratories Company Information
11.15.2 UAS Laboratories Overview
11.15.3 UAS Laboratories Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 UAS Laboratories Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 UAS Laboratories Recent Developments
11.16 Synbiotech
11.16.1 Synbiotech Company Information
11.16.2 Synbiotech Overview
11.16.3 Synbiotech Medical Probiotics Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Synbiotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Synbiotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Probiotics Industry Chain Analysis
12.2 Medical Probiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Probiotics Production Mode & Process
12.4 Medical Probiotics Sales and Marketing
12.4.1 Medical Probiotics Sales Channels
12.4.2 Medical Probiotics Distributors
12.5 Medical Probiotics Customers
13 Market Dynamics
13.1 Medical Probiotics Industry Trends
13.2 Medical Probiotics Market Drivers
13.3 Medical Probiotics Market Challenges
13.4 Medical Probiotics Market Restraints
14 Key Findings in The Global Medical Probiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
表と図のリスト
List of Tables Table 1. Global Medical Probiotics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Table 2. Major Manufacturers of Bifidobacterium Table 3. Major Manufacturers of Lactobacillus Table 4. Major Manufacturers of Others Table 5. Global Medical Probiotics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Table 6. Global Medical Probiotics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 7. Global Medical Probiotics Revenue by Region (2019-2024) & (US$ Million) Table 8. Global Medical Probiotics Revenue by Region (2025-2030) & (US$ Million) Table 9. Global Medical Probiotics Revenue Market Share by Region (2019-2024) Table 10. Global Medical Probiotics Revenue Market Share by Region (2025-2030) Table 11. Global Medical Probiotics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 12. Global Medical Probiotics Sales by Region (2019-2024) & (K MT) Table 13. Global Medical Probiotics Sales by Region (2025-2030) & (K MT) Table 14. Global Medical Probiotics Sales Market Share by Region (2019-2024) Table 15. Global Medical Probiotics Sales Market Share by Region (2025-2030) Table 16. Global Medical Probiotics Sales by Manufacturers (2019-2024) & (K MT) Table 17. Global Medical Probiotics Sales Share by Manufacturers (2019-2024) Table 18. Global Medical Probiotics Revenue by Manufacturers (2019-2024) & (US$ Million) Table 19. Global Medical Probiotics Revenue Share by Manufacturers (2019-2024) Table 20. Global Key Players of Medical Probiotics, Industry Ranking, 2022 VS 2023 VS 2024 Table 21. Medical Probiotics Price by Manufacturers 2019-2024 (USD/MT) Table 22. Global Medical Probiotics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Medical Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Probiotics as of 2023) Table 24. Global Key Manufacturers of Medical Probiotics, Manufacturing Base Distribution and Headquarters Table 25. Global Key Manufacturers of Medical Probiotics, Product Offered and Application Table 26. Global Key Manufacturers of Medical Probiotics, Date of Enter into This Industry Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 29. Global Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 30. Global Medical Probiotics Sales Share by Type (2019-2024) Table 31. Global Medical Probiotics Sales Share by Type (2025-2030) Table 32. Global Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 33. Global Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 34. Global Medical Probiotics Revenue Share by Type (2019-2024) Table 35. Global Medical Probiotics Revenue Share by Type (2025-2030) Table 36. Medical Probiotics Price by Type (2019-2024) & (USD/MT) Table 37. Global Medical Probiotics Price Forecast by Type (2025-2030) & (USD/MT) Table 38. Global Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 39. Global Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 40. Global Medical Probiotics Sales Share by Application (2019-2024) Table 41. Global Medical Probiotics Sales Share by Application (2025-2030) Table 42. Global Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 43. Global Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 44. Global Medical Probiotics Revenue Share by Application (2019-2024) Table 45. Global Medical Probiotics Revenue Share by Application (2025-2030) Table 46. Medical Probiotics Price by Application (2019-2024) & (USD/MT) Table 47. Global Medical Probiotics Price Forecast by Application (2025-2030) & (USD/MT) Table 48. US & Canada Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 49. US & Canada Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 50. US & Canada Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 51. US & Canada Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 52. US & Canada Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 53. US & Canada Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 54. US & Canada Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 55. US & Canada Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 56. US & Canada Medical Probiotics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 57. US & Canada Medical Probiotics Revenue by Country (2019-2024) & (US$ Million) Table 58. US & Canada Medical Probiotics Revenue by Country (2025-2030) & (US$ Million) Table 59. US & Canada Medical Probiotics Sales by Country (2019-2024) & (K MT) Table 60. US & Canada Medical Probiotics Sales by Country (2025-2030) & (K MT) Table 61. Europe Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 62. Europe Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 63. Europe Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 64. Europe Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 65. Europe Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 66. Europe Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 67. Europe Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 68. Europe Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 69. Europe Medical Probiotics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 70. Europe Medical Probiotics Revenue by Country (2019-2024) & (US$ Million) Table 71. Europe Medical Probiotics Revenue by Country (2025-2030) & (US$ Million) Table 72. Europe Medical Probiotics Sales by Country (2019-2024) & (K MT) Table 73. Europe Medical Probiotics Sales by Country (2025-2030) & (K MT) Table 74. China Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 75. China Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 76. China Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 77. China Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 78. China Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 79. China Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 80. China Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 81. China Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 82. Asia Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 83. Asia Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 84. Asia Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 85. Asia Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 86. Asia Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 87. Asia Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 88. Asia Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 89. Asia Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 90. Asia Medical Probiotics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 91. Asia Medical Probiotics Revenue by Region (2019-2024) & (US$ Million) Table 92. Asia Medical Probiotics Revenue by Region (2025-2030) & (US$ Million) Table 93. Asia Medical Probiotics Sales by Region (2019-2024) & (K MT) Table 94. Asia Medical Probiotics Sales by Region (2025-2030) & (K MT) Table 95. Middle East, Africa and Latin America Medical Probiotics Sales by Type (2019-2024) & (K MT) Table 96. Middle East, Africa and Latin America Medical Probiotics Sales by Type (2025-2030) & (K MT) Table 97. Middle East, Africa and Latin America Medical Probiotics Revenue by Type (2019-2024) & (US$ Million) Table 98. Middle East, Africa and Latin America Medical Probiotics Revenue by Type (2025-2030) & (US$ Million) Table 99. Middle East, Africa and Latin America Medical Probiotics Sales by Application (2019-2024) & (K MT) Table 100. Middle East, Africa and Latin America Medical Probiotics Sales by Application (2025-2030) & (K MT) Table 101. Middle East, Africa and Latin America Medical Probiotics Revenue by Application (2019-2024) & (US$ Million) Table 102. Middle East, Africa and Latin America Medical Probiotics Revenue by Application (2025-2030) & (US$ Million) Table 103. Middle East, Africa and Latin America Medical Probiotics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 104. Middle East, Africa and Latin America Medical Probiotics Revenue by Country (2019-2024) & (US$ Million) Table 105. Middle East, Africa and Latin America Medical Probiotics Revenue by Country (2025-2030) & (US$ Million) Table 106. Middle East, Africa and Latin America Medical Probiotics Sales by Country (2019-2024) & (K MT) Table 107. Middle East, Africa and Latin America Medical Probiotics Sales by Country (2025-2030) & (K MT) Table 108. DowDuPont Company Information Table 109. DowDuPont Description and Major Businesses Table 110. DowDuPont Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 111. DowDuPont Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 112. DowDuPont Recent Developments Table 113. Chr. Hansen Company Information Table 114. Chr. Hansen Description and Major Businesses Table 115. Chr. Hansen Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 116. Chr. Hansen Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 117. Chr. Hansen Recent Developments Table 118. Lallemand Company Information Table 119. Lallemand Description and Major Businesses Table 120. Lallemand Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 121. Lallemand Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Lallemand Recent Developments Table 123. China-Biotics Company Information Table 124. China-Biotics Description and Major Businesses Table 125. China-Biotics Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 126. China-Biotics Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 127. China-Biotics Recent Developments Table 128. Nestle Company Information Table 129. Nestle Description and Major Businesses Table 130. Nestle Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 131. Nestle Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Nestle Recent Developments Table 133. Danone Company Information Table 134. Danone Description and Major Businesses Table 135. Danone Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 136. Danone Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 137. Danone Recent Developments Table 138. Probi Company Information Table 139. Probi Description and Major Businesses Table 140. Probi Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 141. Probi Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 142. Probi Recent Developments Table 143. BioGaia Company Information Table 144. BioGaia Description and Major Businesses Table 145. BioGaia Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 146. BioGaia Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 147. BioGaia Recent Developments Table 148. Novozymes Company Information Table 149. Novozymes Description and Major Businesses Table 150. Novozymes Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 151. Novozymes Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Novozymes Recent Developments Table 153. DSM Company Information Table 154. DSM Description and Major Businesses Table 155. DSM Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 156. DSM Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 157. DSM Recent Developments Table 158. Ganeden Company Information Table 159. Ganeden Description and Major Businesses Table 160. Ganeden Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 161. Ganeden Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 162. Ganeden Recent Developments Table 163. Glory Biotech Company Information Table 164. Glory Biotech Description and Major Businesses Table 165. Glory Biotech Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 166. Glory Biotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 167. Glory Biotech Recent Developments Table 168. Unique Biotech Company Information Table 169. Unique Biotech Description and Major Businesses Table 170. Unique Biotech Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 171. Unique Biotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 172. Unique Biotech Recent Developments Table 173. Winclove Probiotics Company Information Table 174. Winclove Probiotics Description and Major Businesses Table 175. Winclove Probiotics Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 176. Winclove Probiotics Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 177. Winclove Probiotics Recent Developments Table 178. UAS Laboratories Company Information Table 179. UAS Laboratories Description and Major Businesses Table 180. UAS Laboratories Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 181. UAS Laboratories Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 182. UAS Laboratories Recent Developments Table 183. Synbiotech Company Information Table 184. Synbiotech Description and Major Businesses Table 185. Synbiotech Medical Probiotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 186. Synbiotech Medical Probiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 187. Synbiotech Recent Developments Table 188. Key Raw Materials Lists Table 189. Raw Materials Key Suppliers Lists Table 190. Medical Probiotics Distributors List Table 191. Medical Probiotics Customers List Table 192. Medical Probiotics Market Trends Table 193. Medical Probiotics Market Drivers Table 194. Medical Probiotics Market Challenges Table 195. Medical Probiotics Market Restraints Table 196. Research Programs/Design for This Report Table 197. Key Data Information from Secondary Sources Table 198. Key Data Information from Primary Sources List of Figures Figure 1. Medical Probiotics Product Picture Figure 2. Global Medical Probiotics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Medical Probiotics Market Share by Type in 2023 & 2030 Figure 4. Bifidobacterium Product Picture Figure 5. Lactobacillus Product Picture Figure 6. Others Product Picture Figure 7. Global Medical Probiotics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 8. Global Medical Probiotics Market Share by Application in 2023 & 2030 Figure 9. Pharmaceuticals Figure 10. Dietary Supplements Figure 11. Others Figure 12. Medical Probiotics Report Years Considered Figure 13. Global Medical Probiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global Medical Probiotics Revenue 2019-2030 (US$ Million) Figure 15. Global Medical Probiotics Revenue Market Share by Region in Percentage: 2023 Versus 2030 Figure 16. Global Medical Probiotics Revenue Market Share by Region (2019-2030) Figure 17. Global Medical Probiotics Sales 2019-2030 ((K MT) Figure 18. Global Medical Probiotics Sales Market Share by Region (2019-2030) Figure 19. US & Canada Medical Probiotics Sales YoY (2019-2030) & (K MT) Figure 20. US & Canada Medical Probiotics Revenue YoY (2019-2030) & (US$ Million) Figure 21. Europe Medical Probiotics Sales YoY (2019-2030) & (K MT) Figure 22. Europe Medical Probiotics Revenue YoY (2019-2030) & (US$ Million) Figure 23. China Medical Probiotics Sales YoY (2019-2030) & (K MT) Figure 24. China Medical Probiotics Revenue YoY (2019-2030) & (US$ Million) Figure 25. Asia (excluding China) Medical Probiotics Sales YoY (2019-2030) & (K MT) Figure 26. Asia (excluding China) Medical Probiotics Revenue YoY (2019-2030) & (US$ Million) Figure 27. Middle East, Africa and Latin America Medical Probiotics Sales YoY (2019-2030) & (K MT) Figure 28. Middle East, Africa and Latin America Medical Probiotics Revenue YoY (2019-2030) & (US$ Million) Figure 29. The Medical Probiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023 Figure 30. The Top 5 and 10 Largest Manufacturers of Medical Probiotics in the World: Market Share by Medical Probiotics Revenue in 2023 Figure 31. Global Medical Probiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 32. Global Medical Probiotics Sales Market Share by Type (2019-2030) Figure 33. Global Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 34. Global Medical Probiotics Sales Market Share by Application (2019-2030) Figure 35. Global Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 36. US & Canada Medical Probiotics Sales Market Share by Type (2019-2030) Figure 37. US & Canada Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 38. US & Canada Medical Probiotics Sales Market Share by Application (2019-2030) Figure 39. US & Canada Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 40. US & Canada Medical Probiotics Revenue Share by Country (2019-2030) Figure 41. US & Canada Medical Probiotics Sales Share by Country (2019-2030) Figure 42. U.S. Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 43. Canada Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 44. Europe Medical Probiotics Sales Market Share by Type (2019-2030) Figure 45. Europe Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 46. Europe Medical Probiotics Sales Market Share by Application (2019-2030) Figure 47. Europe Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 48. Europe Medical Probiotics Revenue Share by Country (2019-2030) Figure 49. Europe Medical Probiotics Sales Share by Country (2019-2030) Figure 50. Germany Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 51. France Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 52. U.K. Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 53. Italy Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 54. Russia Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 55. China Medical Probiotics Sales Market Share by Type (2019-2030) Figure 56. China Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 57. China Medical Probiotics Sales Market Share by Application (2019-2030) Figure 58. China Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 59. Asia Medical Probiotics Sales Market Share by Type (2019-2030) Figure 60. Asia Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 61. Asia Medical Probiotics Sales Market Share by Application (2019-2030) Figure 62. Asia Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 63. Asia Medical Probiotics Revenue Share by Region (2019-2030) Figure 64. Asia Medical Probiotics Sales Share by Region (2019-2030) Figure 65. Japan Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 66. South Korea Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 67. China Taiwan Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 68. Southeast Asia Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 69. India Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 70. Middle East, Africa and Latin America Medical Probiotics Sales Market Share by Type (2019-2030) Figure 71. Middle East, Africa and Latin America Medical Probiotics Revenue Market Share by Type (2019-2030) Figure 72. Middle East, Africa and Latin America Medical Probiotics Sales Market Share by Application (2019-2030) Figure 73. Middle East, Africa and Latin America Medical Probiotics Revenue Market Share by Application (2019-2030) Figure 74. Middle East, Africa and Latin America Medical Probiotics Revenue Share by Country (2019-2030) Figure 75. Middle East, Africa and Latin America Medical Probiotics Sales Share by Country (2019-2030) Figure 76. Brazil Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 77. Mexico Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 78. Turkey Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 79. Israel Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 80. GCC Countries Medical Probiotics Revenue (2019-2030) & (US$ Million) Figure 81. Medical Probiotics Value Chain Figure 82. Medical Probiotics Production Process Figure 83. Channels of Distribution Figure 84. Distributors Profiles Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)